AH
Alan Hutchison
Exec VP Discovery Research

Alan Hutchison insider trades: Neurogen (NRGN) stock sales

Exec VP Discovery Research, Neurogen Last trade Apr 27, 2007 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2005
1
Company
last trade 2007

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Alan reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 27, 2007NRGN↓ Sell$50K
Apr 26, 2007NRGN↓ Sell$22K
Apr 25, 2007NRGN↓ Sell$43K
Apr 24, 2007NRGN↓ Sell$34K
Apr 24, 2007NRGN↓ Sell$695
Apr 23, 2007NRGN↓ Sell$7K
Apr 23, 2007NRGN↓ Sell$17K
May 22, 2006NRGN↓ Sell$109K
Apr 24, 2006NRGN↓ Sell$158K
May 25, 2005NRGN↓ Sell$49K
May 24, 2005NRGN↓ Sell$51K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Alan Hutchison's insider trades

Alan Hutchison is Exec VP Discovery Research at Neurogen (NRGN). Since May 24, 2005, Alan has reported no open-market purchases and 11 sales worth $540K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (6 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NRGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.